Richtlijn: Niet-kleincellig longcarcinoom (2.0) - Kwaliteitskoepel

Richtlijn: Niet-kleincellig longcarcinoom (2.0)248 - Herder GJHerder GJ, Kramer H, Hoekstra OS, Smit EF, Pruim J, van Tinteren H, Comans EF, Verboom P, Uyl-deGroot CA, Welling A, Paul MA, Boers M, Postmus PE, Teule GJ,Groen HJ; POORT Study Group.Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging ofnon-small-cell lung cancer: a Dutch cooperative randomized study. J Clin Oncol 24:1800-1806, 2006249 - Hermanek PHermanek P, Wittekind C. Residual tumor (R) classification and prognosis. Semin Surg Oncol 10:12-20,1994.250 - Herth FJHerth FJ, Eberhardt R, Vilmann P, Krasnik M, Ernst A. Real-time endobronchial ultrasound guidedtransbronchial needle aspiration for sampling mediastinal lymph nodes. Thorax ;61:795-798, 2006.251 - Herth FJHerth FJ, Krasnik M, Kahn N, Eberhardt R, Ernst A. Combined Endoesophageal-EndobronchialUltrasound-Guided, Fine-Needle Aspiration of Mediastinal Lymph Nodes through a Single Bronchoscope in150 Patiënts with Suspected Lung Cancer. Chest PMID: 20154073 Feb 12, 2010.252 - Higashiyama MHigashiyama M, Doi O, Kodama K, Yokouchi H, Tatcishi R, Horai T, et al. Pleural lavage cytologyimmediately after thoracotomy and before closure of the thoracic cavity for lung cancer without pleuraleffusion and dissemination: clinicopathologic and prognostic analysis. Ann Surg Oncol 4:409-415, 1997.253 - Hill KMHill KM, Amir Z, Muers MF, Connolly CK, Round CE. Do newly diagnosed lung cancer patiënts feel theirconcerns are being met? Eur J of Cancer Care 2003. 12; 35-45.254 - Hill KMHill KM. Do newly diagnosed lung cancer patiënts feel their concerns are being met? Eur J of Cancer Care2003.255 - Hillerdal GHillerdal G, Dervnik L, Almgren S, Kling P, Gustafsson G. Prognostic value of malignant cells in pleurallavage at thoracotomy for bronchial carcinoma. Lung Cancer 21:47-52, 1998.256 - Hillers TKHillers TK, Sauve MD, Guyatt GH. Analysis of published studies on the detection of extrathoracicmetastases in patiënts presumed to have operable non-small cell lung cancer. Thorax 49:14-19,1994.257 - Hirsch FRHirsch FR, Spreafico A, Novello S, et al. The prognostic and predictive role of histology in advancednon-small cell lung cancer: A literature review. J Thorac Oncol 3;1468-1481, 2008.258 - Hirsch FRHirsch FR, Varella-Garcia M, Bunn PA Jr, et al. Molecular predictors of outcome with gefitinib in a phase IIIplacebo-controlled study in advanced non–small-cell lung cancer. J Clin Oncol 24:5034–5042, 2006.259 - Hirsch FRHirsch FR, Varella-Garcia M, Cappuzzo F, et al. Combination of EGFR gene copy number and proteinexpression predicts outcome for advanced non-small-cell lung cancer patiënts treated with gefitinib. AnnOncol 18:752-760, 2007.260 - Hofmann HSHofmann HS, Taege C, Lautenschlager C, Neef H, Silber RE. Microscopic (R1) and macroscopic (R2)residual disease in patiënts with resected non-small cell lung cancer. Eur J Cardiothorac Surg 21:606-610,2002.261 - Holaday WJHoladay WJ, Assor D. Ten thousand consecutive frozen sections. A retrospective study focusing on06/09/2011 Niet-kleincellig longcarcinoom (2.0) 112